CasLoc logo
All Cases PTAB Litigations UPC Oppositions

ViiV Healthcare UK Ltd. v. Lupin Ltd.

1:11-cv-00576

Overview

Case Number 1:11-cv-00576
Filing Date 2011-06-29
Status Terminated
Termination Date 2014-01-24
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

11 Attorneys Listed

Ira J. Levy

Email: ilevy@goodwinprocter.com

Lauren M. Nowierski

Email: lnowierski@goodwinprocter.com

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Rivka Jungreis

UNDELIVERABLE EMAIL 6/9/14

Natasha E. Daughtrey

Email: ndaughtrey@goodwinprocter.com

Joshua A. Whitehill

Email: jwhitehill@goodwinprocter.com

Gregory T. Sandidge

Delivery failure 5/22/15

Delivery failure 5/22/15

Eric H. Yecies

Email: eric.yecies@hklaw.com

David M. Hashmall

Email: dhashmall@goodwinprocter.com

Annemarie Hassett

Delivery failure 5/22/15

Delivery failure 5/22/15

Plaintiff

ViiV Healthcare Co. Operating Company

Represented By

5 Attorneys Listed

Counter Claimant

Lupin Ltd. Operating Company

Represented By

10 Attorneys Listed

Lupin Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Counter Defendant

ViiV Healthcare UK Ltd. Operating Company

Represented By

2 Attorneys Listed

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 2 proceedings
🏛️
USPTO PTAB Trials 2 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): GB 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 2 U.S. Courts: 2
USPTO PTAB Trial 2015-01-08
IPR2015-00550

Teva Pharmaceuticals USA, Inc. v. ViiV Healthcare Co. et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2014-06-02
IPR2014-00876

Apotex Corp. v. ViiV Healthcare Co.

Asserted Patent
Status: Terminated-Settled
U.S. District Court 2014-03-21
1:14-cv-00369

ViiV Healthcare UK Ltd. v. Lupin Ltd.

Asserted Patent
Status: DED
U.S. District Court 2011-08-05
1:11-cv-00688

ViiV Healthcare UK Ltd. v. Teva Pharmaceuticals USA Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6417191
Synergistic combinations of zidovudine, 1592U89 and 3TC
Filed: 1996-03-28
Issued: 2002-07-09
Expired (Term Ended)
Expires: 2016-03-28

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
SO ORDERED re 13 STIPULATION TO EXTEND TIME for Lupin Ltd. and Lupin Pharmaceuticals, Inc. to Answer, Move or Otherwise Respond to the Complaint to through and ...
Entry #14 • 2011-09-12 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Lupin Ltd. and Lupin Pharmaceuticals, Inc. to Answer, Move or Otherwise Respond to the Complaint to through and including Septemb...
Entry #13 • 2011-09-06 Document →

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-910591.) - filed by ViiV Healthcare UK Ltd., ViiV Healthcare Co.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dzs, ) (Entered: 06/30/2011)

Entry #1 • 2011-06-29
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dzs, ) (Entered: 06/30/2011)

Entry #2 • 2011-06-29
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/19/11. Date of Expiration of Patent: 3/28/16.Thirty Month Stay Deadline: 11/19/2013. (dzs, ) (Entered: 06/30/2011)

Entry #3 • 2011-06-29
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,417,191;. (dzs, ) (Entered: 06/30/2011)

Entry #4 • 2011-06-29
1

Disclosure Statement pursuant to Rule 7.1 filed by ViiV Healthcare Co., ViiV Healthcare UK Ltd. identifying Corporate Parent ViiV Healthcare UK Ltd. for ViiV Healthcare Co.; Corporate Parent Pfizer Inc., Corporate Parent GlaxoSmithKline plc. for ViiV Healthcare UK Ltd.. (dzs, ) (Entered: 06/30/2011)

Entry #5 • 2011-06-29
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc